Life-course adiposity and severe liver disease: a Mendelian randomization analysis.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 21 07 2023
received: 29 04 2023
accepted: 04 08 2023
medline: 27 11 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

There is little evidence on the genetic associations between life-course adiposity (including birth weight, childhood BMI, and adulthood BMI) and severe liver disease (SLD; including cirrhosis and liver cancer). The current study aimed to examine and contrast these associations. Genetic variants were obtained from genome-wide association studies. Two-sample Mendelian randomization (MR) analyses were performed to assess the genetic associations of life-course adiposity with SLD and liver biomarkers. Cox regression was used to estimate adjusted hazard ratios for SLD associated with genetic risk scores of life-course adiposity and adulthood weight change in the China Kadoorie Biobank. In observational analyses, genetic predispositions to childhood adiposity and adulthood adiposity were each associated with SLD. There was a U-shaped association between adulthood weight change and risk of SLD. In meta-analyses of MR results, genetically predicted 1-standard deviation increase in birth weight was inversely associated with SLD at a marginal significance (odds ratio: 0.81 [95% CI: 0.65-1.00]), whereas genetically predicted 1-standard deviation higher childhood BMI and adulthood BMI were positively associated with SLD (odds ratio: 1.27 [95% CI: 1.05-1.55] and 1.79 [95% CI: 1.59-2.01], respectively). The results of liver biomarkers mirrored those of SLD. The current study provided genetic evidence on the associations between life-course adiposity and SLD.

Identifiants

pubmed: 37869961
doi: 10.1002/oby.23913
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3077-3085

Subventions

Organisme : China Postdoctoral Science Foundation
ID : 2019TQ0008
Organisme : China Postdoctoral Science Foundation
ID : 2020M670071
Organisme : Kadoorie Charitable Foundation
Organisme : Ministry of Science and Technology of the People's Republic of China
ID : 2011BAI09B01
Organisme : National Key Research and Development Program of China
ID : 2016YFC0900500
Organisme : National Natural Science Foundation of China
ID : 81390540
Organisme : National Natural Science Foundation of China
ID : 81941018
Organisme : National Natural Science Foundation of China
ID : 82192900
Organisme : National Natural Science Foundation of China
ID : 82192901
Organisme : National Natural Science Foundation of China
ID : 82192904
Organisme : National Natural Science Foundation of China
ID : 91846303
Organisme : National Natural Science Foundation of China
ID : 82304223
Organisme : Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation
ID : BMU2022RCZX022
Organisme : UK Wellcome Trust
ID : 088158/Z/09/Z
Organisme : UK Wellcome Trust
ID : 104085/Z/14/Z
Organisme : UK Wellcome Trust
ID : 202922/Z/16/Z
Organisme : UK Wellcome Trust
ID : 212946/Z/18/Z

Informations de copyright

© 2023 The Obesity Society.

Références

GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-266.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
Tan DJH, Setiawan VW, Ng CH, et al. Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH. Hepatology. 2023;77(4):1150-1163.
Llovet JM, Willoughby CE, Singal AG, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20:487-503. doi:10.1038/s41575-023-00754-7
Zimmermann E, Berentzen TL, Gamborg M, Sørensen TI, Baker JL. Sex-specific associations between birth weight and adult primary liver cancer in a large cohort of Danish children. Int J Cancer. 2016;138(6):1410-1415.
Berentzen TL, Gamborg M, Holst C, Sørensen TI, Baker JL. Body mass index in childhood and adult risk of primary liver cancer. J Hepatol. 2014;60(2):325-330.
Furer A, Afek A, Sommer A, et al. Adolescent obesity and midlife cancer risk: a population-based cohort study of 2.3 million adolescents in Israel. Lancet Diabetes Endocrinol. 2020;8(3):216-225.
Vithayathil M, Carter P, Kar S, Mason AM, Burgess S, Larsson SC. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: a mendelian randomisation study. PLoS Med. 2021;18(7). doi:10.1371/journal.pmed.1003706
Pang Y, Kartsonaki C, Lv J, et al. Observational and genetic associations of body mass index and hepatobiliary diseases in a relatively lean Chinese population. JAMA Netw Open. 2020;3(10):e2018721. doi:10.1001/jamanetworkopen.2020.18721
Sohn W, Lee HW, Lee S, et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157-174.
World Cancer Research Fund, American Institute for Cancer Research. Body fatness and weight gain and the risk of cancer. 2021. Accessed April 10, 2023;1: https://www.wcrf.org/wp-content/uploads/2021/01/Body-fatness-and-weight-gain_0.pdf.
Yang W, Zeng X, Petrick JL, et al. Body mass index trajectories, weight gain and risks of liver and biliary tract cancers. JNCI Cancer Spectr. 2022;6(4). doi:10.1093/jncics/pkac056
Kim K, Choi S, Lee G, Son JS, Kim KH, Park SM. Association of weight change in young adulthood with subsequent risk of hepatocellular carcinoma: a national cohort study. Eur J Cancer Prev. 2021;30(3):211-219.
Li ZY, Li HL, Ji XW, et al. Dose-response association between adiposity and liver cancer incidence: a prospective cohort study among non-smoking and non-alcohol-drinking Chinese women. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1200-1207.
Christakoudi S, Pagoni P, Ferrari P, et al. Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 2021;148(7):1637-1651.
Simon TG, Kim MN, Luo X, et al. Adiposity, adulthood weight change, and risk of incident hepatocellular carcinoma. Cancer Prev Res. 2021;14(10):945-954.
Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652-1666.
Yang G, Rao C, Ma J, et al. Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol. 2005;35(3):741-748.
Horikoshi M, Beaumont RN, Day FR, et al. Genome-wide associations for birth weight and correlations with adult disease. Nature. 2016;538(7624):248-252. doi:10.1038/nature19806
Felix JF, Bradfield JP, Monnereau C, et al. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index. Hum Mol Genet. 2016;25(2):389-403. doi:10.1093/hmg/ddv472
Fairhurst-Hunter Z, Lin K, Millwood IY, et al. Trans-ancestry meta-analysis improves performance of genetic scores for multiple adiposity-related traits in East Asian populations. Preprint. Posted online July 7, 2022. medRxiv 2022.07.05.22277254. Accessed April 10, 2023. doi:10.1101/2022.07.05.22277254
Wang W, Lv J, Yu C, et al. Lifestyle factors and fetal and childhood origins of type 2 diabetes: a prospective study of Chinese and European adults. Am J Clin Nutr. 2022;115(3):749-758.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508-518.
Zhou W, Nielsen JB, Fritsche LG, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50(9):1335-1341.
Hemani G, Zheng J, Elsworth B, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:7. doi:10.7554/eLife.34408
Shungin D, Winkler TW, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518(7538):187-196.
Fang Z, Giovannucci EL. The timing of adiposity and changes in the life course on the risk of cancer. Cancer Metastasis Rev. 2022;41(3):471-489.
Jia G, Shu XO, Liu Y, et al. Association of adult weight gain with major health outcomes among middle-aged Chinese persons with low body weight in early adulthood. JAMA Netw Open. 2019;2(12):e1917371. doi:10.1001/jamanetworkopen.2019.17371
Hughes AE, Hattersley AT, Flanagan SE, Freathy RM. Two decades since the fetal insulin hypothesis: what have we learned from genetics? Diabetologia. 2021;64(4):717-726.
Farrell G. Insulin resistance, obesity, and liver cancer. Clin Gastroenterol Hepatol. 2014;12(1):117-119.
Clarembeau F, Bale G, Lanthier N. Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clin Sci. 2020;134(16):2117-2135.
Vanni E, Bugianesi E. Obesity and liver cancer. Clin Liver Dis. 2014;18(1):191-203.
Fuchs A, Samovski D, Smith GI, et al. Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. Gastroenterology. 2021;161(3):968-981.
Suliga E. Visceral adipose tissue in children and adolescents: a review. Nutr Res Rev. 2009;22(2):137-147.
Burgess S, Davies NM, Thompson SG, Consortium oboE-I. Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology. 2014;25(6):877-885.
Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample mendelian randomization. Genet Epidemiol. 2016;40(7):597-608.
Shen Z, Yu C, Guo Y, et al. Weight loss since early adulthood, later life risk of fracture hospitalizations, and bone mineral density: a prospective cohort study of 0.5 million Chinese adults. Arch Osteoporos. 2020;15(1):60.

Auteurs

Xinyu Wang (X)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.

Zhiyu Wu (Z)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.

Jun Lv (J)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.

Canqing Yu (C)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.

Dianjianyi Sun (D)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.

Pei Pei (P)

Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.

Ling Yang (L)

Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Iona Y Millwood (IY)

Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Robin Walters (R)

Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Yiping Chen (Y)

Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Huaidong Du (H)

Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Mingqiang Yuan (M)

Pengzhou Center for Disease Control and Prevention, Pengzhou, China.

Dan Schmidt (D)

Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Maxim Barnard (M)

Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Junshi Chen (J)

China National Center for Food Safety Risk Assessment, Beijing, China.

Zhengming Chen (Z)

Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Liming Li (L)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.

Yuanjie Pang (Y)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH